Nineteen treatments recommended as CHMP delivers broad September approvals cycle
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued nineteen positive recommendations between 17 and 21 September 2026, spanning oncology, rheumatology, dermatology, neurology, […]








